Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Henry

Showing results (191-200 of 278) with videos related to

Pageof 28
Sort By:
BMJ Open Gastroenterology|January 16, 2018
Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experiencePeter Nguyen, Philip Vutien, Joseph Hoang, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2022
Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis BLeslie Y Kam, Daniel Q Huang, Alfred F Tobias, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2023
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver diseaseZobair M Younossi, Maria Stepanova, Sean Felix, et al.
Journal of Hepatology|December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2024
Meta-Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSoroor Owrangi, James M Paik, Pegah Golabi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2018
Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patientsVinh Vu, Sam Trinh, An Le, et al.
The Journal of Infectious Diseases|September 28, 2019
Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016Biyao Zou, Yee Hui Yeo, Michael Huan Le, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2022
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)Austin Henry, James M Paik, Patrick Austin, et al.
Journal of Hepatology|May 9, 2021
Surveillance of patients with cirrhosis remains suboptimal in the United StatesYee Hui Yeo, Jungyun Hwang, Donghak Jeong, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Pageof 28

Showing results (191-200 of 278) with videos related to

Sort By:
Pageof 28
BMJ Open Gastroenterology|January 16, 2018
Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experiencePeter Nguyen, Philip Vutien, Joseph Hoang, et al.
Alimentary Pharmacology & Therapeutics|October 21, 2022
Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis BLeslie Y Kam, Daniel Q Huang, Alfred F Tobias, et al.
Alimentary Pharmacology & Therapeutics|March 27, 2023
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver diseaseZobair M Younossi, Maria Stepanova, Sean Felix, et al.
Journal of Hepatology|December 17, 2013
Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C)Zobair M Younossi, Maria Stepanova, Linda Henry, et al.
Alimentary Pharmacology & Therapeutics|December 19, 2024
Meta-Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSoroor Owrangi, James M Paik, Pegah Golabi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2018
Hepatitis B and renal function: A matched study comparing non-hepatitis B, untreated, treated and cirrhotic hepatitis patientsVinh Vu, Sam Trinh, An Le, et al.
The Journal of Infectious Diseases|September 28, 2019
Prevalence of Viremic Hepatitis C Virus Infection by Age, Race/Ethnicity, and Birthplace and Disease Awareness Among Viremic Persons in the United States, 1999-2016Biyao Zou, Yee Hui Yeo, Michael Huan Le, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2022
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)Austin Henry, James M Paik, Patrick Austin, et al.
Journal of Hepatology|May 9, 2021
Surveillance of patients with cirrhosis remains suboptimal in the United StatesYee Hui Yeo, Jungyun Hwang, Donghak Jeong, et al.
Journal of Hepatology|March 10, 2016
Sofosbuvir/velpatasvir improves patient-reported outcomes in HCV patients: Results from ASTRAL-1 placebo-controlled trialZobair M Younossi, Maria Stepanova, Jordan Feld, et al.
Pageof 28